We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HATCH-WAXMAN GENERIC REFORMS BECOMING EVIDENT, OTHER UNKNOWNS LOOM
HATCH-WAXMAN GENERIC REFORMS BECOMING EVIDENT, OTHER UNKNOWNS LOOM
May 4, 2004
While the effects of last year’s drug patent reforms are still sinking in, one change has become clear: The agency has not received a single polymorph patent for filing in the FDA’s Orange Book since the new rules kicked in last August, according to agency officials.